Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus brevis SBC8803 and Improved Sleep Quality

Research synthesisLow evidenceSmall effect7 studies · 7 beneficial · 0 neutral · 0 harmful

Across 7 papers in the database, only one direct human trial (crossover, n=17) specifically tested Lactobacillus brevis SBC8803 for sleep quality. That trial reported a small beneficial effect on waking (p=0.047) and a marginally significant improvement in daytime drowsiness (p=0.067). The remaining 6 studies either examined other probiotic strains or were general reviews not specific to SBC8803, so the aggregate evidence for this particular supplement–outcome pair is very limited.

  • Studied populations: Adults with mild insomnia symptoms (Athens Insomnia Scale score ≥6), based on a single small pilot study in men aged 41–69.

Caveats: Only one small pilot trial (n=17, crossover) directly tested SBC8803; results require replication. The other studies in the database are not specific to this strain, and the observed effect was small and limited to one of several sleep measures reaching statistical significance.

Generated May 11, 2026
10 of 10 papers
Back to top